Metastatic malignant melanoma, lymphoma and PNET (pancreatic neuroendocrine tumor) were also ruled out based on negative results for S100, LCA (Leukocyte common antigen) and CD99, respectively. This evidence concerns the gene PTPRC and pancreatic neuroendocrine tumor.